The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
BriefFDA Press Releases
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar